-
1
-
-
0042840536
-
Predictors of weight loss in adults with topiramate-treated epilepsy
-
Ben-Menachem E, Axelsen M, Johanson EH, et al. Predictors of weight loss in adults with topiramate-treated epilepsy. Obes Res 2003;11:556-62.
-
(2003)
Obes Res
, vol.11
, pp. 556-562
-
-
Ben-Menachem, E.1
Axelsen, M.2
Johanson, E.H.3
-
2
-
-
0346593400
-
A 6-month randomized, placebo-controlled, dose-ranging trial of topiramate for weight loss in obesity
-
Bray GA, Hollander P, Klein S, et al. A 6-month randomized, placebo-controlled, dose-ranging trial of topiramate for weight loss in obesity. Obes Res 2003;11:722-33.
-
(2003)
Obes Res
, vol.11
, pp. 722-733
-
-
Bray, G.A.1
Hollander, P.2
Klein, S.3
-
3
-
-
16644400954
-
Topiramate: Long-term maintenance of weight loss induced by a low-calorie diet in obese subjects
-
Astrup A, Caterson I, Zelissen P, et al. Topiramate: long-term maintenance of weight loss induced by a low-calorie diet in obese subjects. Obes Res 2004;12:1658-69.
-
(2004)
Obes Res
, vol.12
, pp. 1658-1669
-
-
Astrup, A.1
Caterson, I.2
Zelissen, P.3
-
4
-
-
15944367788
-
Meta-analysis: Pharmacologic treatment of obesity
-
Li Z, Maglione M, Tu W, et al. Meta-analysis: pharmacologic treatment of obesity. Ann Intern Med 2005;142:532-46.
-
(2005)
Ann Intern Med
, vol.142
, pp. 532-546
-
-
Li, Z.1
Maglione, M.2
Tu, W.3
-
5
-
-
22144479432
-
Efficacy and safety of topiramate in the treatment of obese subjects with essential hypertension
-
Tonstad S, Tykarski A, Weissgarten J, et al. Efficacy and safety of topiramate in the treatment of obese subjects with essential hypertension. Am J Cardiol 2005;96:243-51.
-
(2005)
Am J Cardiol
, vol.96
, pp. 243-251
-
-
Tonstad, S.1
Tykarski, A.2
Weissgarten, J.3
-
6
-
-
34250842579
-
Weight loss and metabolic effects of topiramate in overweight and obese type 2 diabetic patients: Randomized double-blind placebo-controlled trial
-
Eliasson B, Gudbjörnsdottir S, Cederholm J, et al. Weight loss and metabolic effects of topiramate in overweight and obese type 2 diabetic patients: randomized double-blind placebo-controlled trial. Int J Obes (Lond) 2007;31:1140-7.
-
(2007)
Int J Obes (Lond)
, vol.31
, pp. 1140-1147
-
-
Eliasson, B.1
Gudbjörnsdottir, S.2
Cederholm, J.3
-
7
-
-
33947668881
-
Topiramate in the treatment of obese subjects with drug-naive type 2 diabetes
-
Stenlöf K, Rössner S, Vercruysse F, et al. Topiramate in the treatment of obese subjects with drug-naive type 2 diabetes. Diabetes Obes Metab 2007;9:360-8.
-
(2007)
Diabetes Obes Metab
, vol.9
, pp. 360-368
-
-
Stenlöf, K.1
Rössner, S.2
Vercruysse, F.3
-
8
-
-
33846416927
-
The effect of topiramate on energy balance in obese men: A 6-month double-blind randomized placebo-controlled study with a 6-month open-label extension
-
Tremblay A, Chaput J, Bérubé-Parent S, et al. The effect of topiramate on energy balance in obese men: a 6-month double-blind randomized placebo-controlled study with a 6-month open-label extension. Eur J Clin Pharmacol 2007;63:123-34.
-
(2007)
Eur J Clin Pharmacol
, vol.63
, pp. 123-134
-
-
Tremblay, A.1
Chaput, J.2
Bérubé-Parent, S.3
-
9
-
-
0029962314
-
Clinical characteristics associated with binge eating in obese females: A descriptive study
-
Mussell MP, Mitchell JE, de Zwaan M, et al. Clinical characteristics associated with binge eating in obese females: a descriptive study. Int J Obes Relat Metab Disord 1996;20:324-31.
-
(1996)
Int J Obes Relat Metab Disord
, vol.20
, pp. 324-331
-
-
Mussell, M.P.1
Mitchell, J.E.2
de Zwaan, M.3
-
10
-
-
0027417254
-
Binge eating disorder: Its further validation in a multisite study
-
Spitzer RL, Yanovski S, Wadden T, et al. Binge eating disorder: its further validation in a multisite study. Int J Eat Disord 1993;13:137-53.
-
(1993)
Int J Eat Disord
, vol.13
, pp. 137-153
-
-
Spitzer, R.L.1
Yanovski, S.2
Wadden, T.3
-
12
-
-
0031809290
-
Differences in energy expenditure and substrate oxidation between habitual high fat and low fat consumers (phenotypes)
-
Cooling J, Blundell J. Differences in energy expenditure and substrate oxidation between habitual high fat and low fat consumers (phenotypes). Int J Obes Relat Metab Disord 1998;22:612-18.
-
(1998)
Int J Obes Relat Metab Disord
, vol.22
, pp. 612-618
-
-
Cooling, J.1
Blundell, J.2
-
13
-
-
20444401613
-
Human galanin (GAL) and galanin 1 receptor (GALR1) variations are not involved in fat intake and early onset obesity
-
Schäuble N, Reichwald K, Grassl W, et al. Human galanin (GAL) and galanin 1 receptor (GALR1) variations are not involved in fat intake and early onset obesity. J Nutr 2005;135:1387-92.
-
(2005)
J Nutr
, vol.135
, pp. 1387-1392
-
-
Schäuble, N.1
Reichwald, K.2
Grassl, W.3
-
14
-
-
0034128353
-
Topiramate as add-on therapy: Pooled analysis of randomized controlled trials in adults
-
Reife R, Pledger G, Wu SC. Topiramate as add-on therapy: pooled analysis of randomized controlled trials in adults. Epilepsia 2000;41(Suppl 1):S66-71.
-
(2000)
Epilepsia
, vol.41
, Issue.SUPPL. 1
-
-
Reife, R.1
Pledger, G.2
Wu, S.C.3
-
15
-
-
32944473060
-
Weight change in monozygotic twins treated with valproate
-
Klein KM, Hamer HM, Reis J, et al. Weight change in monozygotic twins treated with valproate. Obes Res 2005;13:1330-4.
-
(2005)
Obes Res
, vol.13
, pp. 1330-1334
-
-
Klein, K.M.1
Hamer, H.M.2
Reis, J.3
-
17
-
-
33645745037
-
Clozapine-induced weight gain: A study in monozygotic twins and same-sex sib pairs
-
Theisen FM, Gebhardt S, Haberhausen M, et al. Clozapine-induced weight gain: a study in monozygotic twins and same-sex sib pairs. Psychiatr Genet 2005;15:285-9.
-
(2005)
Psychiatr Genet
, vol.15
, pp. 285-289
-
-
Theisen, F.M.1
Gebhardt, S.2
Haberhausen, M.3
-
18
-
-
14644417140
-
Clozapine: Weight gain in a pair of monozygotic twins concordant for schizophrenia and mild mental retardation
-
Wehmeier PM, Gebhardt S, Schmidtke J, et al. Clozapine: weight gain in a pair of monozygotic twins concordant for schizophrenia and mild mental retardation. Psychiatry Res 2005;133:273-6.
-
(2005)
Psychiatry Res
, vol.133
, pp. 273-276
-
-
Wehmeier, P.M.1
Gebhardt, S.2
Schmidtke, J.3
|